Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, appointed Marshall Heinberg as its class II director.

Heinberg is a senior adviser to Burford Capital and is the founder and managing director of MAH Associates LLC, which provides strategic advisory and consulting services to various companies. Heinberg will serve as board member until the company's 2019 annual general shareholders meeting.

Tel Aviv, Israel-based Galmed Pharmaceuticals develops therapeutics to treat liver diseases.